Table 13.

Recombinant l-asparaginase children leukemia

Number	Abbreviated title	NCT number	Age	Sponsor
1	Comparative E and S of two asparaginase preparations in children with previously untreated ALL	00784017	1–18 years	Medac Pharma
2	E and S of recombinant asparaginase in infants with previously untreated ALL	00983138	<1 year	Medac Pharma

Notes: The search terms “recombinant l-asparaginase children leukemia” on July 21, 2015 gave six hits. However, four of these studies (NCT00720109, NCT02101853, NCT02003222, NCT02003222) did not use recombinant asparaginase.

Abbreviations: NCT, National Clinical Trial; E, efficacy; S, safety; ALL, acute lymphoblastic leukemia.